… with metastatic prostate cancer receiving androgen deprivation therapy (ADT) had a significantly lower …

… cancer, radiation therapy (RT) in combination with androgen deprivation therapy (ADT) represents … patients received long-term androgen deprivation therapy (ADT), typically 2 … Months After Radiation With Androgen Deprivation Therapy Predicts for Distant …

… robotic assistance. External beam radiation therapy (EBRT): High-energy rays are … may be combined with androgen deprivation therapy (ADT), or hormone therapy, to make the …

… backbone of an androgen receptor pathway inhibitor (ARPI) plus androgen deprivation therapy (ADT) in … 177 vipivotide tetraxetan to standard therapy offers a clinically meaningful improvement … tissues—advanced approaches like proton therapy or MRI-guided SABR …

… high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer Men … of malignancy refractory to bisphosphonate therapy The label notes that Osenvelt …

… , advanced HSPC in combination with androgen deprivation therapy (ADT) and prednisolone or prednisone …

… , FACS, about the use of androgen deprivation therapy (ADT) in prostate cancer management …

… risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer, … receiving adjuvant aromatase inhibitor therapy for breast cancer. Stoboclo … risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer …

… high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer. … receiving an adjuvant aromatase inhibitor therapy for breast cancer. Osenvelt … of malignancy refractory to bisphosphonate therapy. According to a news …

… -emitting or β-emitting radioligand therapy combinations.” The investigator-initiated, single … with at least 1 androgen receptor pathway inhibitor and … patients received concurrent androgen deprivation therapy, and bone antiresorptive therapy was mandated per …